Incidence, outcome and future projections of atrial fibrillation-related stroke and systemic embolism at age >=80 years: 10-year results of a population-based study.
Prevalence of atrial fibrillation (AF) is increasing and now affects over 10% of individuals aged ≥80 years. Warfarin is effective in preventing thromboembolic events, but is substantially under-used in the elderly, and use of new anticoagulants at age ≥80 years is also limited. We determined the in...
Prif Awduron: | Yiin, G, Howard, D, Paul, N, Mehta, Z, Rothwell, P |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2013
|
Eitemau Tebyg
-
Incidence, outcome and future projections of atrial fibrillation-related stroke and systemic embolism at age >/=80 years: 10-year results of the Oxford Vascular Study
gan: Yiin, G, et al.
Cyhoeddwyd: (2013) -
Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study.
gan: Yiin, G, et al.
Cyhoeddwyd: (2014) -
POPULATION-BASED STUDY OF TEMPORAL TRENDS IN ATRIAL FIBRILLATION RELATED INCIDENT ISCHAEMIC STROKE: EVIDENCE OF SUBSTANTIAL FAILURE OF PRIMARY PREVENTION
gan: Yiin, G, et al.
Cyhoeddwyd: (2012) -
A population-based study of incidence and outcome of atrial fibrillation-related thromboembolic events: implications for primary prevention
gan: Howard, D, et al.
Cyhoeddwyd: (2014) -
Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation
gan: Yiin, G, et al.
Cyhoeddwyd: (2018)